Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation
Population
98,811 adults who developed new non-valvular atrial fibrillation between 2004-2012, mean age ~72, 50% women…
Design
Cohort
Follow-up
2004-2012
Authors
Discussion
Loading...
Member takes
Implication
Highlights gaps in real-world AF anticoagulation; leaves open optimal strategies to improve persistence and outcomes.
Structured PICO
P
Population
98,811 adults who developed new non-valvular atrial fibrillation between 2004-2012 (from a database of 2,420,000 adults), mean age ~72, 50% women, 46% with cardiovascular disease, 6% with prior stroke.
O
Outcome
Prevalence, incidence, management (warfarin use and time in therapeutic range), and outcomes (ischemic stroke and death)hard clinical
This large national cohort study highlights a significant gap in stroke prevention for patients with incident non-valvular atrial fibrillation, demonstrating low rates of persistent warfarin use and suboptimal time in therapeutic range.
Cite This Study
Haim et al. (2015) studied this question.